Correlation Between Tel Aviv and Bonus Biogroup

Can any of the company-specific risk be diversified away by investing in both Tel Aviv and Bonus Biogroup at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tel Aviv and Bonus Biogroup into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tel Aviv 35 and Bonus Biogroup, you can compare the effects of market volatilities on Tel Aviv and Bonus Biogroup and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tel Aviv with a short position of Bonus Biogroup. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tel Aviv and Bonus Biogroup.

Diversification Opportunities for Tel Aviv and Bonus Biogroup

-0.9

Correlation Coefficient

Tel Aviv  Bonus Biogroup

Pay attention - limited upside

The 3 months correlation between Tel and Bonus is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Tel Aviv 35 and Bonus Biogroup in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bonus Biogroup and Tel Aviv is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tel Aviv 35 are associated (or correlated) with Bonus Biogroup. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bonus Biogroup has no effect on the direction of Tel Aviv i.e., Tel Aviv and Bonus Biogroup go up and down completely randomly.

Pair Corralation between Tel Aviv and Bonus Biogroup

Assuming the 90 days trading horizon Tel Aviv 35 is expected to generate 0.45 times more return on investment than Bonus Biogroup. However, Tel Aviv 35 is 2.22 times less risky than Bonus Biogroup. It trades about 0.35 of its potential returns per unit of risk. Bonus Biogroup is currently generating about -0.21 per unit of risk. If you would invest  201,921  in Tel Aviv 35 on September 15, 2024 and sell it today you would earn a total of  31,625  from holding Tel Aviv 35 or generate 15.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Tel Aviv 35  vs.  Bonus Biogroup

Pair Trading with Tel Aviv and Bonus Biogroup

The main advantage of trading using opposite Tel Aviv and Bonus Biogroup positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tel Aviv position performs unexpectedly, Bonus Biogroup can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bonus Biogroup will offset losses from the drop in Bonus Biogroup's long position.

The idea behind Tel Aviv 35 and Bonus Biogroup pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.